Discover 1,436 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,436
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
for
Parkinson Disease
Location: Bellevue WA, Portland OR, Los Angeles CA, Aurora CO,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 40 - 70+
Code: NCT06976268
Phase2, Phase3, Recruiting
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Bellevue WA, Walnut Creek CA, San Jose CA, Las Vegas NV,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06830044
Phase3, Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Cytokinetics
Sex: All
Age: 40 - 70+
Code: NCT06793371
Phase2, Recruiting
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis (gMG)
Location: Seattle WA, Portland OR, Sacramento CA,
Sponsor: Cabaletta Bio
Sex: All
Age: 18 - 70
Code: NCT06359041
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
EffectiveNess and SAfety of Small ANeurysm COiling Trial
for
Aneurysm
Location: Seattle WA, Saskatoon, Santa Barbara CA, Englewood CO,
Sponsor: University of Virginia
Sex: All
Age: 18 - 70+
Code: NCT02167997
Recruiting
FORWARD CAD IDE Study
for
Coronary Arterial Disease (CAD)
Location: Bellevue WA, Seattle WA, Portland OR, San Francisco CA,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT06662500
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Bellevue WA, Portland OR, San Francisco CA, Stanford CA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
New
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
for
Human Papilloma Virus (HPV),
Location: Seattle WA, Layton UT, Phoenix AZ, Little Rock AR
Sponsor: Daré Bioscience, Inc.
Sex: Female
Age: 22 - 50
Code: NCT07601074
Phase2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Seattle WA, Tacoma WA, Olympia WA, Salem OR, Spokane WA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase3, Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Seattle WA, Edmonds WA, San Francisco CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase1, Phase2, Recruiting
Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone
for
Substance-Related Disorders
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18 - 40
Code: NCT00504413
Phase1, Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Seattle WA, Edmonds WA, Los Angeles CA, Winnipeg,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05061550
Phase2, Recruiting
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
for
B-cell Malignancies
Location: Seattle WA, Calgary, La Jolla CA, Rochester MN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06542250
Phase1, Phase2, Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis